HCT Regenerative is the first company in Taiwan to focus on processing human tissue to provide orthobiologics and regenerative biomaterials for clinical use.


HCT Regenerative is partnered with LifeLink Tissue Bank to expand and support tissue transplantation for patients in Taiwan.


All tissue is processed in a class 10,000 cleanroom using aseptic technique. The processing procedures include a cleaning and disinfecting process with microbiological testing.

Our tissue bank is TFDA approved and we strive to follow American tissue banking standards.


HCT Regenerative is devoted to developing advanced human cellular and tissue based products (HCT/Ps) to improve patients' quality of life.  

Our current tissue products are AmnioGen® a dehydrated amniotic membrane allograft and LifeGraft® a spinal allograft designed to promote fushion.

Copyright © HCT Regenerative. All rights reserved.